Inhibition of interleukin-1β-induced activation of MEK/ERK pathway and DNA binding of NF-κB and AP-1: Potential mechanism for Diacerein effects in osteoarthritis

Biorheology

Volumn 43, Issue 3-4, 2006, Pages 577-587

  Domagala, F ^b   Martin, G ^a   Bogdanowicz, P ^a   Ficheux, H ^b   Pujol, J P ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b Laboratoires Negma   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; DIACETYLRHEIN; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECOMBINANT INTERLEUKIN 1BETA; RHEIN; TRANSCRIPTION FACTOR AP 1; ANTHRAQUINONE DERIVATIVE; COLLAGENASE; DNA BINDING PROTEIN; I KAPPA B; INTERLEUKIN 1; LECTIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEOCHONDROITIN SULFATE; SCLEROPROTEIN;

ANIMAL CELL; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; INFLAMMATION; NONHUMAN; NORTHERN BLOTTING; OSTEOARTHRITIS; WESTERN BLOTTING; ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; CELL HYPOXIA; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGGRECANS; ANIMALS; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARTILAGE, ARTICULAR; CATTLE; CELL HYPOXIA; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; COLLAGENASES; DNA-BINDING PROTEINS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; I-KAPPA B PROTEINS; INTERLEUKIN-1; LECTINS, C-TYPE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PROTEOCHONDROITIN SULFATES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 33747142674     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. H. Asahara, K. Fujisawa, T. Kobata, T. Hasunuma, T. Maeda, M. Asanuma, N. Ogawa, H. Inoue, T. Sumida and K. Nishioka, Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium, Arthritis Rheum. 40(5) (1997), 912-918.
2. M. Boittin, F. Redini, G. Loyau and J.P. Pujol, Effect of Diacerhein (ART 50) on the matrix synthesis and collagenase secretion by cultured joint chondrocytes in rabbits, Rev. Rhum. Ed. Fr. 60(6 Pt 2) (1993), 68S-76S.
3. K.D. Brandt, G. Smith, S.Y. Kang, S. Myers, B. O'Connor and M. Albrecht, Effects of Diacerhein in an accelerated canine model of osteoarthritis, Osteoarthritis Cartilage 5(6) (1997), 438-449.
4. C.E. Brinckerhoff, Regulation of metalloproteinase gene expression: implications for osteoarthritis, Crit. Rev. Eukaryot. Gene Expr. 2 (1992), 145-164.
5. G. Buttice, S. Quinones and M. Kurkinen, The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene, Nucleic Acids Res. 19(13) (1991), 3723-3731.
6. F.M. Cicuttini and T.D. Spector, Osteoarthritis in the aged. Epidemiological issues and optimal management, Drugs Aging 6 (1995), 409-420.
7. W. Conca, P.B. Kaplan and S.M. Krane, Increases in levels of procollagenase messenger RNA in cultured fibroblasts induced by human recombinant interleukin 1 beta or serum follow c-jun expression and are dependent on new protein synthesis, J. Clin. Invest. 83(5) (1989), 1753-1757.
8. J.A. DiBattista, J.P. Pelletier, M. Zafarullah, N. Fujimoto, K. Obata and J. Martel-Pelletier, Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts, J. Rheumatol. Suppl. 43 (1995), 123-128.
9. Dong Qian, Hai-Yan Lin, Hong-Mei Wang, Xuan Zhang, Dong-Lin Liu, Qing-Lei Li and Cheng Zhu, Normoxic induction of the hypoxic-inducible factor-1α by interleukin-1β involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells, Biol. Reprod. 70(6) (2004), 1822-1827.
10. M. Dougados, M. Nguyen, L. Berdah, B. Mazieres, E. Vignon and M. Lequesne, ECHODIAH Investigators Study Group Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the chondromodulating effect of Diacerein in OA of the hip, Arthritis Rheum. 44(11) (2001), 2539-2547.
11. N. Felisaz, K. Boumediene, C. Ghayor, J.F. Herrouin, P. Bogdanowicz, P. Galerra and J.P. Pujol, Stimulating effect of diacerein on TGF-beta1 and beta2 expression in articular chondrocytes cultured with and without interleukin-1, Osteoarthritis Cartilage 7(3) (1999), 255-264.
12. Y. Geng, F.J. Blanco, M. Cornelisson and M. Lotz, Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes, J. Immunol. 155 (1995), 796-801.
13. M.B. Goldring, The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models, Connect. Tissue. Res. 40 (1999), 1-11.
14. D. Hamerman, Aging and osteoarthritis: basic mechanisms, J. Am. Geriatr. Soc. 41 (1993), 760-770.
15. L. Haywood, D.F. McWilliams, C.I. Pearson et al., Inflammation and angiogenesis in osteoarthritis, Arthritis Rheum. 48 (2003), 2173-2177.
16. C. Huang, W.Y. Ma, M.R. Youngm, N. Colburn and Z. Dong, Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells, Proc. Natl. Acad. Sci. USA 95(1) (1998), 156-161.
17. B.L. Kidd and L.A. Urban, Mechanisms of inflammatory pain, Br. J. Anaesth. 87 (2001), 3-11.
18. J.M. Kyriakis and J. Avrach, Protein kinase cascades activated by stress and inflammatory cytokines, Bioessays 18 (1996), 567-577.
19. T. Lehmann, L.Q. Nguyen and M.L. Handel, Synovial fluid induced nuclear factor-kappaB DNA binding in a monocytic cell line, J. Rheumatol. 27(12) (2000), 2769-2776.
20. M. Lotz, F.J. Blanco, J. von Kempis, J. Dudler, R. Maier, P.M. Villiger and Y. Geng, Cytokine regulation of chondrocyte functions, J. Rheumatol. Suppl. 43 (1995), 104-108.
21. G. Loyau and J.P. Pujol, The role of cytokines in the development of osteoarthritis, Scand. J. Rheumatol. Suppl. 81 (1990), 8-12.
22. W.J. Lukiw and N.G. Bazan, Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex, J. Neurosci. Res. 53(5) (1998), 583-592.
23. C.J. Marshall, Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation, Cell 80 (1995), 179-185.
24. J. Martel-Pelletier, F. Mineau, F.C. Jolicoeur, J.M. Cloutier and J.P. Pelletier, In vitro effects of Diacerhein and Rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes, J. Rheumatol. 25(4) (1998), 753-762.
25. G. Martin, R. Andriamanalijaona, S. Grassel, R. Dreier, M. Mathy-Hartert, P. Bogdanowicz, K. Boumediene, Y. Henrotin, P. Bruckner and J.P. Pujol, Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes, Arthritis Rheum. 50(11) (2004), 3549-3560.
26. G. Martin, R. Andriamanalijaona, S. Grassel, R. Dreier, M. Mathy-Hartert, P. Bogdanowicz, K. Boumediene, Y. Henrotin, P. Bruckner and J.P. Pujol, Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes, Arthritis Rheum. 50(11) (2004), 3549-3560.
27. J.A. Mengshol, M.P. Vincenti, C.I. Coon, A. Barchowsky and C.E. Brinckerhoff, Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3, Arthritis Rheum. 43 (2000), 801-811.
28. C.J. Menkes, D. Borderie, A. Hernvann and O. Ekindjian, Inhibition by Rhein of nitrosothiol production of human chondrocytes from osteoarthritis in culture, Bull. Acad. Natl. Med. 183(4) (1999), 785-795; discussion 795-796.
29. J. Middleton, A. Manthey and J. Tyler, Insulin-like growth factor (IGF) receptor, IGF-I, interleukin-1 beta (IL-1 beta), and IL-6 mRNA expression in osteoarthritic and normal human cartilage, J. Histochem. Cytochem. 44 (1996), 133-141.
30. A.R. Moore, K.J. Greenslade, C.A. Alam and D.A. Willoughby, Effects of Diacerhein on granuloma induced cartilage breakdown in the mouse, Osteoarthritis Cartilage 6(1) (1998), 19-23.
31. C.L. Murphy and A. Sambanis, Effect of oxygen tension and alginate encapsulation on restoration of the differentiated phenotype of passaged chondrocytes, Tissue Eng. 7(6) (2001), 791-803.
32. R.M. Palmer, M.S. Hickery, I.G. Charles, S. Moncada and M.T. Bayliss, Induction of nitric oxide synthase in human chondrocytes, Biochem. Biophys. Res. Commun. 193(1) (1993), 398-405.
33. J.P. Pelletier, F. Mineau, J.C. Fernandes, N. Duval and J. Martel-Pelletier, Diacerhein and Rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes, J. Rheumatol. 25(12) (1998), 2417-2424.
34. A.M. Pendas, M. Balbin, E. Llano, M.G. Jimenez and C. Lopez-Otin, Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13), Genomics 40(2) (1997), 222-233.
35. S. Philip, A. Bulbule and G.C. Kundu, Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion, Glycoconj. J. 21(8-9) (2004), 429-441.
36. P. Reboul, J.P. Pelletier, G. Tardif, J.M. Cloutier and J. Martel-Pelletier, The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis, J. Clin. Invest. 97 (1996), 2011-2019.
37. C. Sanchez, M. Mathy-Hartert, M.A. Deberg, H. Ficheux, J.Y. Reginster and Y.E. Henrotin, Effects of Rhein on human articular chondrocytes in alginate beads, Biochem. Pharmacol. 65(3) (2003), 377-388.
38. J.D. Sandy, Proteolytic degradation of normal and osteoarthritic cartilage matrix, in: K.D. Brandt, M. Doherty, L.S. Lohmander, eds, Osteoarthritis, Oxford University Press, New York, 2003, pp. 82-91.
39. G.N. Smith, Jr., S.L. Myers, K.D. Brandt, E.A. Mickler and M.E. Albrecht, Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis, Arthritis Rheum. 42(3) (1999), 545-554.
40. T.D. Spector, D.J. Hart, D. Nandra et al., Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease, Arthritis Rheum. 40 (1997), 723-727.
41. J. Stadler, M. Stefanovic-Racic, T.R. Billiar, R.D. Curran, L.A. McIntyre, H.I. Georgescu, R.L. Simmons and C.H. Evans, Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide, J. Immunol. 147 (1991), 3915-3920.
42. P.P. Tak and S.G. Firestein, NF-κB: a key role in inflammatory diseases, J. Clin Invest. 107(1) (2001), 7-11.
43. C.I. Westacott, J.T. Whicher, I.C. Barnes, D. Thompson, A.J. Swan and P.A. Dieppe, Synovial fluid concentration of five different cytokines in rheumatic diseases, Ann. Rheum. Dis. 49(9) (1990), 676-681.
44. M. Yaron, I. Shirazi and I. Yaron, Anti-interleukin-1 effects of diacerein and Rhein in human osteoarthritic synovial tissue and cartilage cultures, Osteoarthritis Cartilage 7(3) (1999), 272-280.